Neuroprot Flashcards

(25 cards)

1
Q

What does MD stand for in dietary studies?

A

Mediterranean diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What have clinical trials of curcumin yielded?

A

Negative or inconclusive results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What effect did resveratrol have in animal models?

A

Reduced plaque pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is turmeric scientifically known as?

A

Curcuma longa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What did the 2015 double-blind study find about omega-3 PUFAs?

A

Negligible benefit of supplementation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What did the 2008 double-blind study find regarding omega-3 fatty acids?

A

Improved general clinical function in mild AD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What may curcumin’s role be in Alzheimer’s disease?

A

Protective agent rather than reversal agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do epidemiological studies suggest about omega-3 PUFAs?

A

They may reduce the risk of cognitive decline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What association was found between vegetable consumption and dementia risk?

A

Frequent consumption lowers dementia risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can curcumin’s bioavailability be increased?

A

By piperin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What types of vegetables showed the strongest associations with lower dementia risk?

A

Cruciferous, legumes, and green leafy vegetables

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does curcumin modulate in relation to diseases?

A

Targets relevant for cancer and cardiovascular diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is required for future studies on omega-3 PUFAs?

A

Large sample sizes and longer duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What did preclinical studies suggest about curcumin’s efficacy?

A

Supported efficacy against AD pathophysiological features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What was the effect of high-dose curcumin (5000 ppm)?

A

Possibly suppressed amyloid clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What effect did curcumin have in transgenic mice regarding amyloid pathology?

A

Reduction of amyloid pathology observed

17
Q

What evidence is lacking regarding fruit intake and dementia risk?

A

No strong association found for fruit intake

18
Q

What did apple consumption do in rats?

R

A

Reduced anxious behavior and restored synaptic function

19
Q

What effects did Souvenaid® show in pre-clinical models?

What has been observed regarding the effects of Souvenaid® in clinical studies?

What has been the safety profile of Souvenaid®?

A

Increased synthesis of phospholipids and neuronal membranes - Preclin

Effects are controversial - Clin

No harmful effects associated so far

= A medical nutrition formulation presented as a drink

20
Q

What is a significant issue with curcumin’s bioavailability?

A

Low absorption and rapid metabolism

21
Q

What does resveratrol modulate in relation to neurodegeneration?

A

Numerous targets involved in neurodegeneration

22
Q

What were the findings regarding resveratrol’s safety?

A

Safe and well-tolerated

23
Q

What was the conclusion regarding cognitive and behavioral outcomes with resveratrol?

A

No significant effects observed

24
Q

What are the key findings regarding dietary factors and Alzheimer’s disease?

A

*Omega-3 PUFAs may reduce cognitive decline risk
*Clinical trials show weak effects of omega-3s
*Curcumin shows promise but inconclusive clinical results
*Resveratrol reduces plaque pathology in animal models
*High vitamin C and E intake may lower Alzheimer’s risk
*Apple juice and coffee constituents show protective effects
*Saffron and blueberry improve cognitive performance in tria

25
What are the limitations of current studies on dietary supplements for Alzheimer's disease?
*Many clinical trials yield negative or inconclusive results *Small sample sizes in some studies *Short duration of clinical trials *Poor bioavailability of some supplements *Need for larger, longer studies